Clinical Trials

The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

by ClinicalTrialsFeed • 2016/02/23 • 0 Comments

Status: Recruiting, Condition Summary: Thyroid Eye Disease

← Cryoablation improves visual acuity, other outcomes in eyes with active pars planitis

Two Johns Hopkins scientists named among 105 winners of Presidential Early Career Awards →